Regulation of lipoprotein lipase by Angptl4

Trends in Endocrinology and Metabolism

Volumn 25, Issue 3, 2014, Pages 146-155

  Dijk, Wieneke ^a   Kersten, Sander ^a  

^a WAGENINGEN UNIVERSITY   (Netherlands)

Author keywords

Angiopoietin like 4; Glycosylphosphatidylinositol anchored high density lipoprotein binding protein; Hypertriglyceridemia; Lipoprotein lipase; Proprotein convertases

Indexed keywords

ANGIOPOIETIN-LIKE 4; GLYCOSYLPHOSPHATIDYLINOSITOL-ANCHORED HIGH DENSITY LIPOPROTEIN-BINDING PROTEIN; HYPERTRIGLYCERIDEMIA; LIPOPROTEIN LIPASE; PROPROTEIN CONVERTASES;

ADIPOSE TISSUE; ANGIOPOIETINS; FATTY ACIDS; HUMANS; LIPOPROTEIN LIPASE; PEROXISOME PROLIFERATOR-ACTIVATED RECEPTORS; PROPROTEIN CONVERTASES;

EID: 84894387971     PISSN: 10432760     EISSN: 18793061     Source Type: Journal    
DOI: 10.1016/j.tem.2013.12.005     Document Type: Review

References (102)

1. Wang H., Eckel R.H. Lipoprotein lipase: from gene to obesity. Am. J. Physiol. Endocrinol. Metab. 2009, 297:E271-E288.
2. Young S.G., Zechner R. Biochemistry and pathophysiology of intravascular and intracellular lipolysis. Genes Dev. 2013, 27:459-484.
3. Klop B., et al. Dyslipidemia in obesity: mechanisms and potential targets. Nutrients 2013, 5:1218-1240.
4. Köster A., et al. Transgenic angiopoietin-like (angptl)4 overexpression and targeted disruption of angptl4 and angptl3: regulation of triglyceride metabolism. Endocrinology 2005, 146:4943-4950.
5. Mandard S., et al. The fasting-induced adipose factor/angiopoietin-like protein 4 is physically associated with lipoproteins and governs plasma lipid levels and adiposity. J. Biol. Chem. 2006, 281:934-944.
6. Lee E., et al. Identification of a new functional domain in angiopoietin-like 3 (ANGPTL3) and angiopoietin-like 4 (ANGPTL4) involved in binding and inhibition of lipoprotein lipase (LPL). J. Biol. Chem. 2009, 284:13735-13745.
7. Desai U., et al. Lipid-lowering effects of anti-angiopoietin-like 4 antibody recapitulate the lipid phenotype found in angiopoietin-like 4 knockout mice. Proc. Natl. Acad. Sci. U.S.A. 2007, 104:11766-11771.
8. Shimizugawa T., et al. ANGPTL3 decreases very low density lipoprotein triglyceride clearance by inhibition of lipoprotein lipase. J. Biol. Chem. 2002, 277:33742-33748.
9. Wang Y., et al. Mice lacking ANGPTL8 (Betatrophin) manifest disrupted triglyceride metabolism without impaired glucose homeostasis. Proc. Natl. Acad. Sci. U.S.A. 2013, 110:16109-16114.
10. Quagliarini F., et al. Atypical angiopoietin-like protein that regulates ANGPTL3. Proc. Natl. Acad. Sci. U.S.A. 2012, 109:19751-19756.
11. Zandbergen F., et al. Fasting-induced adipose factor/angiopoietin-like protein 4: a potential target for dyslipidemia?. Future Lipidol. 2006, 1:227-236.
12. Zhang R., Abou-Samra A.B. Emerging roles of Lipasin as a critical lipid regulator. Biochem. Biophys. Res. Commun. 2013, 432:401-405.
13. Kersten S., et al. Characterization of the fasting-induced adipose factor FIAF, a novel peroxisome proliferator-activated receptor target gene. J. Biol. Chem. 2000, 275:28488-28493.
14. Yoon J.C., et al. Peroxisome proliferator-activated receptor γ target gene encoding a novel angiopoietin-related protein associated with adipose differentiation. Mol. Cell. Biol. 2000, 20:5343-5349.
15. Kim I., et al. Hepatic expression, synthesis and secretion of a novel fibrinogen/angiopoietin-related protein that prevents endothelial-cell apoptosis. Biochem. J. 2000, 346:603-610.
16. Zhu P., et al. Angiopoietin-like 4: a decade of research. Biosci. Rep. 2012, 32:211-219.
17. Mattijssen F., Kersten S. Regulation of triglyceride metabolism by Angiopoietin-like proteins. Biochim. Biophys. Acta 2012, 1821:782-789.
18. Arca M., et al. The angiopoietin-like protein 3: a hepatokine with expanding role in metabolism. Curr. Opin. Lipidol. 2013, 24:313-320.
19. Ge H., et al. Oligomerization and regulated proteolytic processing of angiopoietin-like protein 4. J. Biol. Chem. 2004, 279:2038-2045.
20. Lei X., et al. Proteolytic processing of angiopoietin-like protein 4 by proprotein convertases modulates its inhibitory effects on lipoprotein lipase activity. J. Biol. Chem. 2011, 286:15747-15756.
21. Yau M.H., et al. A highly conserved motif within the NH2-terminal coiled-coil domain of angiopoietin-like protein 4 confers its inhibitory effects on lipoprotein lipase by disrupting the enzyme dimerization. J. Biol. Chem. 2009, 284:11942-11952.
22. Lichtenstein L., et al. Angptl4 upregulates cholesterol synthesis in liver via inhibition of LPL- and HL-dependent hepatic cholesterol uptake. Arterioscler. Thromb. Vasc. Biol. 2007, 27:2420-2427.
23. Yin W., et al. Genetic variation in ANGPTL4 provides insights into protein processing and function. J. Biol. Chem. 2009, 284:13213-13222.
24. Sukonina V., et al. Angiopoietin-like protein 4 converts lipoprotein lipase to inactive monomers and modulates lipase activity in adipose tissue. Proc. Natl. Acad. Sci. U.S.A. 2006, 103:17450-17455.
25. Chomel C., et al. Interaction of the coiled-coil domain with glycosaminoglycans protects angiopoietin-like 4 from proteolysis and regulates its antiangiogenic activity. FASEB J. 2009, 23:940-949.
26. Ge H., et al. Oligomerization state-dependent hyperlipidemic effect of angiopoietin-like protein 4. J. Lipid Res. 2004, 45:2071-2079.
27. Mandard S., et al. The direct peroxisome proliferator-activated receptor target fasting-induced adipose factor (FIAF/PGAR/ANGPTL4) is present in blood plasma as a truncated protein that is increased by fenofibrate treatment. J. Biol. Chem. 2004, 279:34411-34420.
28. Koliwad S.K., et al. Angiopoietin-like 4 (ANGPTL4, fasting-induced adipose factor) is a direct glucocorticoid receptor target and participates in glucocorticoid-regulated triglyceride metabolism. J. Biol. Chem. 2009, 284:25593-25601.
29. Robal T., et al. Fatty acids bind tightly to the N-terminal domain of angiopoietin-like protein 4 and modulate its interaction with lipoprotein lipase. J. Biol. Chem. 2012, 287:29739-29752.
30. Makoveichuk E., et al. Inactivation of lipoprotein lipase occurs on the surface of THP-1 macrophages where oligomers of angiopoietin-like protein 4 are formed. Biochem. Biophys. Res. Commun. 2012, 425:138-143.
31. Robciuc M.R., et al. Angiopoietin-like 4 mediates PPAR delta effect on lipoprotein lipase-dependent fatty acid uptake but not on beta-oxidation in myotubes. PLoS ONE 2012, 7:e46212.
32. Georgiadi A., et al. Induction of cardiac Angptl4 by dietary fatty acids is mediated by peroxisome proliferator-activated receptor beta/delta and protects against fatty acid-induced oxidative stress. Circ. Res. 2010, 106:1712-1721.
33. Brands M., et al. Omega-3 long-chain fatty acids strongly induce angiopoietin-like 4 in humans. J. Lipid Res. 2013, 54:615-621.
34. González-Muniesa P., et al. Fatty acids and hypoxia stimulate the expression and secretion of the adipokine ANGPTL4 (angiopoietin-like protein 4/fasting-induced adipose factor) by human adipocytes. J. Nutrigenet Nutrigenomics 2011, 4:146-153.
35. Kersten S., et al. Caloric restriction and exercise increase plasma ANGPTL4 levels in humans via elevated free fatty acids. Arterioscler. Thromb. Vasc. Biol. 2009, 29:969-974.
36. Yoshida K., et al. Angiopoietin-like protein 4 is a potent hyperlipidemia-inducing factor in mice and inhibitor of lipoprotein lipase. J. Lipid Res. 2002, 43:1770-1772.
37. Makoveichuk E., et al. Inactivation of lipoprotein lipase in 3T3-L1 adipocytes by angiopoietin-like protein 4 requires that both proteins have reached the cell surface. Biochem. Biophys. Res. Commun. 2013, 441:941-946.
38. Lafferty M.J., et al. Angiopoietin-like protein 4 inhibition of lipoprotein lipase: Evidence for reversible complex formation. J. Biol. Chem. 2013, 288:28524-28534.
39. Beigneux A.P., et al. Glycosylphosphatidylinositol-anchored high-density lipoprotein-binding protein 1 plays a critical role in the lipolytic processing of chylomicrons. Cell Metab. 2007, 5:279-291.
40. Davies B.S.J., et al. GPIHBP1 is responsible for the entry of lipoprotein lipase into capillaries. Cell Metab. 2010, 12:42-52.
41. Gin P., et al. The acidic domain of GPIHBP1 is important for the binding of lipoprotein lipase and chylomicrons. J. Biol. Chem. 2008, 283:29554-29562.
42. Sonnenburg W.K., et al. GPIHBP1 stabilizes lipoprotein lipase and prevents its inhibition by angiopoietin-like 3 and angiopoietin-like 4. J. Clin. Nutr. 2009, 50:2421-2429.
43. Nilsson S.K., et al. Triacylglycerol-rich lipoproteins protect lipoprotein lipase from inactivation by ANGPTL3 and ANGPTL4. Biochim. Biophys. Acta 2012, 1821:1370-1378.
44. Cazes A., et al. Extracellular matrix-bound angiopoietin-like 4 inhibits endothelial cell adhesion, migration, and sprouting and alters actin cytoskeleton. Circ. Res. 2006, 99:1207-1215.
45. Goh Y.Y., et al. Angiopoietin-like 4 interacts with integrins beta1 and beta5 to modulate keratinocyte migration. Am. J. Pathol. 2010, 177:2791-2803.
46. Mead J.R., et al. Lipoprotein lipase: structure, function, regulation, and role in disease. J. Mol. Med. 2002, 80:753-769.
47. Kroupa O., et al. Linking nutritional regulation of Angptl4, Gpihbp1, and Lmf1 to lipoprotein lipase activity in rodent adipose tissue. BMC Physiol. 2012, 12:13.
48. Kim H.K., et al. Hypothalamic Angptl4/Fiaf is a novel regulator of food intake and body weight. Diabetes 2010, 59:2772-2780.
49. Yamada T., et al. Insulin downregulates angiopoietin-like protein 4 mRNA in 3T3-L1 adipocytes. Biochem. Biophys. Res. Commun. 2006, 347:1138-1144.
50. Gray N.E., et al. Angiopoietin-like 4 (Angptl4) protein is a physiological mediator of intracellular lipolysis in murine adipocytes. J. Biol. Chem. 2012, 287:8444-84456.
51. Robciuc M.R., et al. Serum angiopoietin-like 4 protein levels and expression in adipose tissue are inversely correlated with obesity in monozygotic twins. J. Lipid Res. 2011, 52:1575-1582.
52. Sanderson L.M., et al. Peroxisome proliferator-activated receptor beta/delta (PPARbeta/delta) but not PPARalpha serves as a plasma free fatty acid sensor in liver. Mol. Cell. Biol. 2009, 29:6257-6267.
53. Yao Q., et al. Effect of chronic intermittent hypoxia on triglyceride uptake in different tissues. J. Lipid Res. 2013, 54:1058-1065.
54. Ge H., et al. Differential regulation and properties of angiopoietin-like proteins 3 and 4. J. Lipid Res. 2005, 46:1484-1490.
55. Van Raalte D.H., et al. Angiopoietin-like protein 4 is differentially regulated by glucocorticoids and insulin in vitro and in vivo in healthy humans. Exp. Clin. Endocrinol. 2012, 120:598-603.
56. Teusink B., et al. Contribution of fatty acids released from lipolysis of plasma triglycerides to total plasma fatty acid flux and tissue-specific fatty acid uptake. Diabetes 2003, 52:614-620.
57. Yu X., et al. Inhibition of cardiac lipoprotein utilization by transgenic overexpression of Angptl4 in the heart. Proc. Natl. Acad. Sci. U.S.A. 2005, 102:1767-1772.
58. Wang Y., et al. Severity of diabetes governs vascular lipoprotein lipase by affecting enzyme dimerization and disassembly. Diabetes 2011, 60:2041-2050.
59. Wu G., et al. A transcription-dependent mechanism, akin to that in adipose tissue, modulates lipoprotein lipase activity in rat heart. Am. J. Physiol. Endocrinol. Metab. 2007, 293:E908-E915.
60. An D., et al. The metabolic 'switch' AMPK regulates cardiac heparin-releasable lipoprotein lipase. Am. J. Physiol. Endocrinol. Metab. 2005, 288:E246-E253.
61. Kiens B. Skeletal muscle lipid metabolism in exercise and insulin resistance. Physiol. Genomics 2006, 86:205-243.
62. Dutton S., Trayhurn P. Regulation of angiopoietin-like protein 4/fasting-induced adipose factor (Angptl4/FIAF) expression in mouse white adipose tissue and 3T3-L1 adipocytes. Br. J. Nutr. 2008, 100:18-26.
63. Davies P.J., et al. Metabolic effects of rexinoids: tissue-specific regulation of lipoprotein lipase activity. Mol. Pharm. 2001, 59:170-176.
64. Quig D.W., et al. The influence of starvation and refeeding on the lipoprotein lipase activity of skeletal muscle and adipose tissue of lean and obese Zucker rats. J. Nutr. 1983, 113:1150-1156.
65. Ladu M.J., et al. Regulation of lipoprotein lipase in adipose and muscle tissues during fasting. Am. J. Physiol. 1991, 260:R953-R959.
66. Hakvoort T.B.M., et al. Interorgan coordination of the murine adaptive response to fasting. J. Biol. Chem. 2011, 286:16332-16343.
67. Pilegaard H., et al. Effect of short-term fasting and refeeding on transcriptional regulation of metabolic genes in human skeletal muscle. Diabetes 2003, 52:657-662.
68. Seip R.L., et al. Exercise induces human lipoprotein lipase gene expression in skeletal muscle but not adipose tissue. Am. J. Physiol. Endocrinol. Metab. 1995, 268:E229-E236.
69. Seip R.L., et al. Induction of human skeletal muscle lipoprotein lipase gene expression by short-term exercise is transient. Am. J. Physiol. Endocrinol. Metab. 1997, 272:E255-E261.
70. Mattijssen F., et al. Angptl4 serves as endogenous inhibitor of intestinal lipid digestion. Mol. Metab. 2013, 10.1016/j.molmet.2013.11.004.
71. Alex S., et al. Short-chain fatty acids stimulate angiopoietin-like 4 synthesis in human colon adenocarcinoma cells by activating peroxisome proliferator-activated receptor γ. Mol. Cell. Biol. 2013, 33:1303-1316.
72. Bäckhed F., et al. The gut microbiota as an environmental factor that regulates fat storage. Proc. Natl. Acad. Sci. U.S.A. 2004, 101:15718-15723.
73. Fleissner C.K., et al. Absence of intestinal microbiota does not protect mice from diet-induced obesity. Br. J. Nutr. 2010, 104:919-929.
74. Camp J.G., et al. Intronic cis-regulatory modules mediate tissue-specific and microbial control of angptl4/fiaf transcription. PLoS Genet. 2012, 8:e1002585.
75. El Aidy S., et al. The gut microbiota elicits a profound metabolic reorientation in the mouse jejunal mucosa during conventionalisation. Gut 2013, 62:1306-1314.
76. Aronsson L., et al. Decreased fat storage by Lactobacillus paracasei is associated with increased levels of angiopoietin-like 4 protein (ANGPTL4). PLoS ONE 2010, 5:e13087.
77. Are A., et al. Enterococcus faecalis from newborn babies regulate endogenous PPARgamma activity and IL-10 levels in colonic epithelial cells. Proc. Natl. Acad. Sci. U.S.A. 2008, 105:1943-1948.
78. Korecka A., et al. ANGPTL4 expression induced by butyrate and rosiglitazone in human intestinal epithelial cells utilize independent pathways. Am. J. Physiol. Gastrointest. Liver Physiol. 2013, 304:G1025-G1033.
79. Bäckhed F., et al. Mechanisms underlying the resistance to diet-induced obesity in germ-free mice. Proc. Natl. Acad. Sci. U.S.A. 2007, 104:979-984.
80. Georgiadi A., et al. Overexpression of angiopoietin-like protein 4 protects against atherosclerosis development. Arterioscler. Thromb. Vasc. Biol. 2013, 33:1529-1537.
81. Evans A.J., et al. Evidence that cholesteryl ester and triglyceride accumulation in J774 macrophages induced by very low density lipoprotein subfractions occurs by different mechanisms. J. Lipid Res. 1993, 34:703-717.
82. Yin B., et al. Lipoprotein lipase regulates Fc receptor-mediated phagocytosis by macrophages maintained in glucose-deficient medium. J. Clin. Nutr. 1997, 100:649-657.
83. Van Eck M., et al. Role of macrophage-derived lipoprotein lipase in lipoprotein metabolism and atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 2000, 20:E53-E62.
84. Adachi H., et al. Angptl 4 deficiency improves lipid metabolism, suppresses foam cell formation and protects against atherosclerosis. Biochem. Biophys. Res. Commun. 2009, 379:806-811.
85. Lichtenstein L., et al. Angptl4 protects against severe proinflammatory effects of saturated fat by inhibiting fatty acid uptake into mesenteric lymph node macrophages. Cell Metab. 2010, 12:580-592.
86. Romeo S., et al. Population-based resequencing of ANGPTL4 uncovers variations that reduce triglycerides and increase HDL. Nat. Genet. 2007, 39:513-516.
87. Smart-Halajko M.C., et al. The relationship between plasma angiopoietin-like protein 4 levels, angiopoietin-like protein 4 genotype, and coronary heart disease risk. Arterioscler. Thromb. Vasc. Biol. 2010, 30:2277-2282.
88. Jonker J.T., et al. Dietary modulation of plasma angiopoietin-like protein 4 concentrations in healthy volunteers and in patients with type 2 diabetes. J. Clin. Nutr. 2013, 97:255-260.
89. Robciuc M.R., et al. Quantitation of serum angiopoietin-like proteins 3 and 4 in a Finnish population sample. J. Lipid Res. 2010, 51:824-831.
90. Stejskal D., et al. Angiopoietin-like protein 4: development, analytical characterization, and clinical testing of a new ELISA. Gen. Physiol. Biophys. 2008, 27:59-63.
91. Adhikary T., et al. Inverse PPARβ/δ agonists suppress oncogenic signaling to the ANGPTL4 gene and inhibit cancer cell invasion. Oncogene 2012, 32:5241-5252.
92. Staiger H., et al. Muscle-derived angiopoietin-like protein 4 is induced by fatty acids via peroxisome proliferator-activated receptor (PPAR)-delta and is of metabolic relevance in humans. Diabetes 2009, 58:579-589.
93. Weinstock P.H., et al. Severe hypertriglyceridemia, reduced high density lipoprotein, and neonatal death in lipoprotein lipase knockout mice. Mild hypertriglyceridemia with impaired very low density lipoprotein clearance in heterozygotes. J. Clin. Nutr. 1995, 96:2555-2568.
94. Lookene A., et al. Rapid subunit exchange in dimeric lipoprotein lipase and properties of the inactive monomer. J. Biol. Chem. 2004, 279:49964-49972.
95. Kobayashi Y., et al. Molecular modeling of the dimeric structure of human lipoprotein lipase and functional studies of the carboxyl-terminal domain. Eur. J. Biochem. 2002, 269:4701-4710.
96. Zhang L., et al. Calreticulin promotes folding/dimerization of human lipoprotein lipase expressed in insect cells (sf21). J. Biol. Chem. 2003, 278:29344-29351.
97. Ben-Zeev O., et al. Maturation of lipoprotein lipase in the endoplasmic reticulum. Concurrent formation of functional dimers and inactive aggregates. J. Biol. Chem. 2002, 277:10727-10738.
98. Péterfy M., et al. Mutations in LMF1 cause combined lipase deficiency and severe hypertriglyceridemia. Nat. Genet. 2007, 39:1483-1487.
99. Enerbäck S., et al. Tissue-specific regulation of guinea pig lipoprotein lipase; effects of nutritional state and of tumor necrosis factor on mRNA levels in adipose tissue, heart and liver. Gene 1988, 64:97-106.
100. Wu G., et al. Rapid downregulation of adipose tissue lipoprotein lipase activity on food deprivation: evidence that TNF-alpha is involved. Am. J. Physiol. Endocrinol. Metab. 2004, 286:E711-E717.
101. Bergö M., et al. Down-regulation of adipose tissue lipoprotein lipase during fasting requires that a gene, separate from the lipase gene, is switched on. J. Biol. Chem. 2002, 277:11927-11932.
102. Zhang L., et al. Calcium triggers folding of lipoprotein lipase into active dimers. J. Biol. Chem. 2005, 280:42580-42591.